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Protein dephosphorylation by protein phosphatase 1 (PP1), acting in concert with protein kinase C (PKC) and 
protein kinase A (PKA), is a pivotal regulatory mechanism of protein phosphorylation. Isolated rat cardiac 
myofibrils phosphorylated by PKC/PKA and dephosp h o r y l a t e d  b y  P P 1  w e r e  u s e d  i n  d e t e r m i n i n g  
dephosphorylation specificities, Ca2+-stimulated Mg2+ATPase activities, and Ca2+ sensitivities. In reconstituted 
troponin (Tn) complex, PP1 displayed distinct substrate specificity in dephosphorylation of TnT preferentially to 
TnI, in vitro. In situ phosphorylation of cardiomyocytes with calyculin A, a protein phosphatase inhibitor, 
resulted in an increase in the phosphorylation stiochiometry of TnT (0.3 to 0.5 (67%)), TnI (2.6 to 3.6 (38%)), and 
MLC2 (0.4 to 1.7 (325%)). These results further confirmed that though MLC2 is the preferred target substrate for 
protein phosphatase in the thick filament, the Tn complex (TnI and TnT) from thin filament and C-protein in the 
thick filament are also protein phosphatase substrates. Our in vitro dephosphorylation experiments revealed 
that while PP1 differentially dephosphorylated within TnT at multiple sites, TnI was uniformly 
dephosphorylated.  Phosphopeptide maps from the in vitro experiments show that TnT phosphopeptides at 
spots 4A and 4B are much more resistant to PP1 dephosphorylation than other TnT phosphopeptides. 
Mg2+ATPase assays of myofibrils phosphorylated by PKC/PKA and dephosphorylated by PP1 delineated that 
while PKC and PKA phosphorylation decreased the Ca2+-stimulated Mg2+ATPase activities, dephosphorylation 
antagonistically restored it. PKC and PKA phosphorylation decreased Ca2+ sensitivity to 3.6 µM and 5.0 µM 
respectively. However, dephosphorylation restored the Mg2+ATPase activity of PKC (99%) and PKA (95%), 
along with the Ca2+ sensitivities (3.3 µM and 3.0 µM, respectively).   
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1.  Introduction  
Protein dephosphorylation, acting in concert 
with protein phosphorylation has become 
increasingly appreciated as a fundamental 
mechanism in controlling phosphorylation states of 
proteins, which play a cardinal role in the regulation 
of biological activities such as cardiac muscle 
contraction and relaxation [1]. Evidence exists that 
there is a significant increase of PP2A activity in the 
myocardium of transgenic mice [2]. It has been shown 
that the subcellular localization of two B subunits 
(B56α and B56γ1) of PP2A were assessed in cultured 
neonatal and adult rat ventricular myocytes [3]. One 
of the roles of protein phosphatases in cardiac muscle 
physiology is its ability to stimulate calcium release in 
cardiac myocytes [4, 5]. Of several serine/threonine 
protein phosphatases identified to date, PP1 is unique 
in its particulate localizations and substrate 
specificities. All forms of PP1 holoenzymes (110 kD) 
appear to share a similar 37-kD catalytic subunit 
(PP1C), but differ in the associated regulatory 
subunits. It has been shown that these different 
regulatory subunits are crucial for targeting the 
holoenzymes to specific subcellular locations and 
hence enabling them to act preferentially on specific 
substrates in these locations [6-8]. Accordingly, PP1 
holoenzymes have been classified into the following 
subspecies: PP1G, which is associated with glycogen 
particle or sarcoplasmic reticulum; PP1, with 
myofibrils; and PP1N, with the nucleus [1]. PP1 has 
been purified from skeletal and cardiac muscle [6-7] 
and smooth muscle [8], and their properties 
characterized [6-8]. Because PP1 represents about 60 
to 90% of the phosphatase activity toward native 
myosin in rabbit skeletal muscle and bovine cardiac 
muscle, respectively, it has been suggested that this 
enzyme is primarily responsible for 
dephosphorylating MLC2 in vivo [6-7]. PP1/PP2A 
have also been shown to play a role in regulation of 
cardiac inotropy and relaxation [9] and that inhibiting 
these enzymes with calyculin A (CCA) affects the 
excitation-contraction coupling cascade in murine 
ventricular myocytes [9-10].   
Dephosphorylation of native myosin or isolated 
MLC2 has been used for assaying the PP1 activity in 
p r e v i o u s  s t u d i e s  [ 6 - 8 ] .  I n  a d d i t i o n  t o  M L C 2  i n  t h e  
thick filament, reversible phosphorylation also occurs 
in other myofibrillar proteins. These proteins include, 
notably, C- protein in the thick filament, and Tnl and 
TnT in the thin filament [11, 12]. As others and we Int. J. Biol. Sci. 2006, 2  2
have reported, PKC phosphorylates cardiac TnI and 
TnT in vitro [12-19] and in situ in cardiomyocytes 
[12, 20] at multiple sites, leading to decreases in 
maximal activity and/or Ca2+ sensitivity of Ca2+-
stimulated Mg2+ATPase of reconstituted actomyosin 
[15-19] or native myofibrils [12, 17]. With the use of a 
number of phosphorylation site- substitution and -
deletion mutants of cardiac TnI, we found that PKC 
phosphorylation of Ser-43/Ser-45 and Ser-23/Ser-24 
resulted in decreased activity and Ca2+ sensitivity, 
respectively, of Ca2+ -stimulated Mg2+ATPase of 
reconstituted actomyosin S-1 [19]. Others and we also 
reported that PKC isozymes has shown to be 
expressed in adult rat cardiomyocytes [21-25], 
exhibited distinct intermolecular specificities in 
differentially phosphorylating Tnl and TnT subunits 
in the Tn complex, as well as intermolecular 
specificities in differentially phosphorylating multiple 
sites within TnI and TnT [25]. PKC-δ was unique 
among the isozymes in its ability to favorably 
phosphorylate Ser-23/Ser-24 in Tnl, the bonafide 
phosphorylation sites for PKA [25], and hence 
functioned as a hybrid of typical PKC and PKA in the 
regulation of myofilament properties [25]. It was 
recently reported by others that Ca2+-/calmodulin-
dependent protein kinase phosphatase 
dephosphorylates and regulates multifunctional 
Ca2+/calmodulin-dependent  protein kinase [27]. 
Incubation of isolated adult rat cardiomyocytes with 
CCA, a potent inhibitor of PPI and PP2A [1], resulted 
in elevated phosphorylation of Tnl, TnT, and MLC2 
[12, 20], indicating that dephosphorylation of 
contractile proteins was an active process.   
We suspected that PP1 could not only effectively 
act on Tnl and TnT in the thin filament as it does on 
MLC2 in the thick filament [6-8] but could 
differentially dephosphorylate TnI and TnT at 
multiple sites within them that are phosphorylated by 
PKC and/or PKA. Also, we suspected that PP1 could 
antagonistically restore myofibrillar Mg2+ATPase 
activity and Ca2+sensitivity to normal following 
PKC/PKA phosphorylation. In the present study, we 
have examined these issues, as well as, the functional 
consequences of dephosphorylation of Tnl and/or 
TnT.  
2.  Materials and methods  
Preparation of protein phosphates  
PP1 was purified from adult male Sprauge-
Dawley rat hearts. Crude extract was obtained by 
mincing and grinding of rat fat-free cardiac 
ventricular muscles in buffer A (containing 50 mM 
imidazole chloride, 5 mM EDTA, and 0.5 mM DTT 
(pH 7.5)) and centrifuging at 3300 x g for 30 min. The 
supernatant containing the crude extract was filtered 
through glass wool, brought to neutral pH by adding 
solid potassium bicarbonate, and brought to 70% 
saturation with ammonium sulfate by the addition of 
solid salt (43.6 g/100ml) and stirring.  Ammonium 
sulfate was precipitated by allowing the extract to 
stand on ice for 1h and centrifuged at 3300 x g for 30 
min. The precipitate was resuspended in buffer A 
(room temperature) and mixed with 95% ethanol. The 
resulting suspension was centrifuged at 3300 x g for 5 
min and the precipitate was resuspended in buffer A, 
followed by centrifugation at 10,000 x g for 20 min. 
The extract was resuspended in buffer A (4 fold 
diluted buffer A) and dialyzed for 3 h, followed by 
dialysis in buffer C (2 fold dilution of buffer A) for 3 
h, and finally dialyzed overnight in buffer A. The 
dialyzed enzyme solution was loaded onto a DEAE-
Sepharose column (5 × 9 cm) previously equilibrated 
with buffer A.  The column was washed with 0.1 M 
NaCl/buffer A and the enzyme eluted with 0.5 M 
NaCl/buffer A. Fractions were assayed for 
phosphorylase phosphatase activity. Fractions with 
phosphorylase phosphatase activity were dialyzed 
for 2-3 h against buffer A and loaded onto a DEAE -
Sepharose column (2.5 × 90 cm) previously 
equilibrated with buffer A. The column was washed 
with 0.1 M NaCl/buffer A and then eluted with a 
linear gradient of 0.1 to 0.5M NaCl. Fractions were 
assayed for PP1 and PP2 (usually fractions in peak 1 
contained PP1 and peak 2 contained PP2). Fractions 
of PP1 were pooled, dialyzed, and loaded onto a 
haperin-Sepharose column previously equilibrated 
with buffer A/20% glycerol. The column was washed 
with 0.1 M NaCl/buffer A/20% glycerol and PP1 
eluted with 0.5 M NaCl/buffer A/20% glycerol. 
Fractions with PP1 activity was pooled and 
chromatographed on a Sephacryl S-200 column 
equilibrated with 0.3 M NaCl/buffer A/20% glycerol. 
Active fractions were dialyzed against 50% 
buffer/50% glycerol and stored at -20°C.  
Preparation of rat cardiac myofibrils   
Myofibrils were extracted from rat ventricular 
myocardia by detergent extraction as described by 
Murphy and Solaro [28]. Briefly, rat ventricles were 
minced and homogenized in cold standard buffer (60 
mM KCl, 30 mM imidazole (pH 7.0) and 2 mM 
MgCl2) and centrifuged at 12,000 x g for 15 min. The 
pellet was resuspended in 1 volume of solution (10 
mM EGTA, 8.2 mM MgCl2, 14.4 mM KCl, 60 mM 
imidazole (pH 7.0), 5.5 mM ATP, 0.01mg/ml protease 
inhibitors (leupeptin, antipain, aprotinin and 
pepstatin), and 1% triton X – 100) and was allowed to 
incubate on ice for 30 min. The suspension was 
washed three times with standard buffer and stored 
in -70 °C.   
Reconstituion of rat cardiac Tn complex   
Reconstituted rat cardiac Tn complex was 
prepared as we previously reported [19, 25, 29].   
Briefly, TnI and TnT were mixed in 10 mM imidazole 
HCl (pH 7.0) containing 6 M urea, 1 mM CaCl2, and 
1mM DTT at a molar ratio of 1:1.  The mixture was 
dialyzed for 48 h at 4°C against 10 mM imidazole HCl 
(pH 7.0) containing 1 mM magnesium acetate and 1 
mM DTT with a KCl concentration of 1.0, 0.7, 0.3, and 
0.1 M.  This mixture was then concentrated using 
ultrafiltration.  Formation of the Tn complex was Int. J. Biol. Sci. 2006, 2  3
verified by gel filtration chromatography on Bio-Gel 
A-0.5 M (Bio-Rad®).   
Phosphorylation of rat cardiac reconstituted Tn 
complex   
Reconstituted rat cardiac Tn complex was 
phosphorylated, as described elsewhere, using PKC 
[19, 25, 29].  Briefly, reaction mixture (0.4ml) 
containing 50 mM Tris-HCl (pH 7.5) 10 mM MgCl2, 
1.0mM DTT, 0.9 mM CaCl2, 0.5 mM EGTA, 0.3 M 
KCl, 5 µM [γ-32 P] ATP (2-4 × 106  cpm), 
phosphotidylserine (38µg/ml), diolein (5µg/ml), 100 
nM TPA, and 4 µM reconstituted Tn.  The reaction 
was carried out for 60 min. at 30°C.  The γ-32 P 
labeled Tn was anaylyzed by SDS- polyacrylamide 
gel electrphoresis.  
Phosphorylation of cardiac myofibrils   
Rat cardiac myofibrils were phosphorylated 
using brain PKC as we previously reported [19, 25, 
29]. The γ-32P labeled myofibrils were then analyzed 
by direct precipitation with 5% trichloroacetic acid 
containing tungstate. Bovine serum albumin was 
used as a carrier protein during precipitation of the 
myofibrils. Phosphorylation of myofibrils was 
visualized using sodium dodecyl sulfate (SDS) 
polyacrylamide gel electrophoresis (PAGE) followed 
by autoradiography. Phosphorylation by PKA was 
carried out as in brain PKC except that 10 mM cAMP 
replaced PS/Ca2+/diolein as an activator.  
In situ phosphorylation of rat ventricular myofibrils  
Isolated cardiomyocytes were incubated (1.5 
hour at 37° C) in phosphate free Dulbecco’s modified 
eagle’s medium (DMEM) and metabolically labeled 
using phosphorus-32 (32P).  Samples were pelleted 
and washed in buffer A (1 mM PMSF, 100 µg/ml 
leupeptin, 100 µg/ml antipain, 100 µg/ml pepstatin 
A, 0.1 mM NaOV, 100 nM CCA, and 5 mM EGTA), 
sonicated in buffer B (50 mM KH2PO4, 70 mM NaF, 5 
mM EDTA, 1% Triton X-100, protease inhibitors, and 
phosphatase inhibitors), iced for 30 min., and washed 
in modified buffer B (without Triton X-100).  The 
phosphorylations of samples were visualized by SDS-
PAGE and autoradiography.  
Dephosphorylation of phosphorylated rat cardiac 
reconstituted Tn  and rat ventricular myofibrils  
Previously,  γ-32 P labeled reconstituted 
troponin phosphorylated by PKC was 
dephosphorylated by PP1 according to a modified 
method of Venema et al. [20].  32P-labeled Tn was 
incubated with PP1 (10 units/ml) in 20 mM Hepes 
buffer (0.2 mM MnCl2, 1 mM DDT, 0.5 mM CaCl2, 
0.04 mM EDTA, and 200 mM KCl) (pH 7.5).  A 
parallel experiment with myelin base protein (MBP) 
was used as a dephosphorylation control, since MBP 
is a very well known substrate for PP1.  Samples from 
the incubation mixture were removed for 
dephosphorylation analysis at 0, 2, 10, 30, 60, and 120 
min. intervals. Dephosphorylation of PKC and PKA 
phosphorylated myofibrils was performed as 
described above except that samples from the 
incubating mixture were removed for 
dephosphorylation analysis by SDS-PAGE at 0, 10, 30, 
and 60 min intervals.The dephosphorylation analysis 
was carried out by SDS-PAGE, followed by 
autoradiography.    
Two dimensional phosphopeptide mapping  
Two dimensional phosphopeptide mapping of 
phosphorylated and dephosphorylated TnI, TnT, and 
MLC2 was performed as we previously described [19, 
25, 29]. γ-32P labeled TnI, TnT, and MLC2 were 
excised from the gel and extracted using 0.2 M 
ammonium bicarbonate buffer (pH 8.6). Extracts were 
exhaustively digested with 50µl of 2 mg /ml trypsin 
at 37°C for 17 h. 25 µl of trypsin was added for an 
additional 7 hours. The digested phosphopeptide 
supernatant was separated from the gel by 
centrifugation. The supernatant was degassed by 
addition of 5µl of glacial acetic acid and vortexed. The 
phosphopeptides were lyophilized, and spotted on 
precoated thin layer chromatography (TLC) sheets. 
Electrophoresis in the first dimension was carried out 
for 2 h at 450 V in pyridine: acetic acid: water (1:10:89, 
v/v). Column chromatography in the second 
dimension was performed in butanol:pyridine:acetic 
acid:water (125:100:3:125, v/v). The phosphopeptide 
spots were visualized by autoradiography.  
Determination of Ca
2+- stimulated Mg
2+ATPase 
activity of phosphorylated myofibrils   
Ca2+-stimulated Mg2+ATPase activity was 
assayed according to the methods of Noland and Kuo 
[18] using previously 
phosphorylated/dephosphorylated cardiac 
myofibrils. The assay was carried out at 30°C for 10 
min in standard reaction mixtures (0.5 ml) containing 
50 µg of rat cardiac myofibrils, 10 mM MOPS-KOH 
(PH 7.0), 4.1 mM Mg acetate, 2.1mM [γ-32P] ATP (5-8 
x 106 CPM), 1 mM DTT, 1 mM EGTA, and 1.05 mM 
CaCl2 (the free Ca2+  was calculated to be 40 mM). 
CaCl2, when present, was added as a mixture with 
EGTA and MOPS-KOH to give calculated free Ca2+ 
concentration of 0.01-100 mM in the assay mixture. 
KCl was added to bring the final ionic strength to 18 
mM. The reactions were initiated by addition of 
radioactive ATP, terminated by addition of 10% 
charcoal suspension, and the released 32Pi was 
determined as we recently reported [25, 29].   
3.  Results  
It was observed that PP1, a serine/threonine 
protein phosphatase effectively dephosphorylated C-
protein, TnT and Tnl in the thin filament, as 
suspected, and in MLC2 in the thick filament, as 
reported by others [6-8]. PP1 catalyzed 
dephosphorylation acted in concert with PKC 
catalyzed phosphorylation of myofibrillar proteins. 
PP1 substrate specificity in the dephosphorylation 
was confirmed by the result obtained from 
dephosphorylating PKC phosphorylated 
reconstituted Tn complex (Fig. 1). In this experiment, Int. J. Biol. Sci. 2006, 2  4
PP1 displayed distinct substrate specificity in 
dephosphorylation of TnT preferentially to TnI. It is 
observed that TnT was almost completely 
dephosphorylated within the first 30 min of the 
dephosphorylation experiment, whereas TnI was still 
resistant to PP1 dephosphorylation even after 120 min 
of the experiment. Myelin basic protein (MBP) 
dephosphorylation by PP1 used as a control because 
it is a well-known substrate for PP1 confirmed this 
result that Tn complex is also an excellent PP1 
substrate.  PP1 substrate specificity in the 
dephosphorylation was also confirmed by the result 
obtained from dephosphorylating PKC and PKA 
phosphorylated myofibrils, in  vitro (Fig. 2). This 
time-dependent dephosphorylation of the myofibrils 
revealed that PP1 dephosphorylation of PKC 
phosphorylated myofibrils were uniformly 
dephosphorylated starting between 0-10 min. of the 
dephosphorylation experiment.  In  situ 
phosphorylation of cardiomyocytes incubated with 
CCA, a PP1 and PP2A inhibitor, was used to 
determine which myofibrillar proteins are 
dephosphorylated by PP1/PP2A in  situ  (Fig. 3). 
Phosphorylation stiochiometry of TnT from the in 
situ experiment increased from 0.3 to 0.5 (67%), TnI 
from 2.6 to 3.6 (38%), and MLC2 0.4 to 1.7 (325%). 
From this experiment, it is therefore concluded that 
though MLC2 is the preferred target substrate for PP1 
in the thick filament [6-8] the Tn complex (TnI and 
TnT) is also a PP1 and PP2A substrate in the thin 
filament, as we suspected.  
Fig. 1. Autoradiogram of PP1 mediated time dependent 
dephosphorylation patterns of PKC phosphorylated TnT 
and TnI. 
32P-labeled reconstituted Tn complex was 
incubated with PP1 (10 units/ml) in 20 mM Hepes buffer 
(0.2 mM MnCl2, 1 mM DDT, 0.5 mM CaCl2, 0.04 mM 
EDTA, and 150-300 mM KCl) (pH 7.5) for 5-120 min at 
22°C. Dephosphorylation of myelin basic protein (MBP) 
was used as a control. The findings were confirmed by 
three other experiments.  
 
Fig. 2. Autoradiogram of PKC in vitro phosphorylated 
rat cardiac myofibrils time dependent dephosphorylation 
by PP1. 
32P-labeled myofibrils were incubated with PP1 
(10 units/ml) in 20 mM Hepes buffer (0.2 mM MnCl2, 1 
mM DDT, 0.5 mM CaCl2, 0.04 mM EDTA, and 150-300 
mM KCl) (pH 7.5) for 0-60 min at 22°C. The findings were 
confirmed by three other experiments.  
 
Fig. 3. Autoradiogram showing the effects of protein 
phosphatase  in  situ dephosphorylation on rat 
cardiomyocytes without (A) and with (B) calyculin A. 
Isolated cardiomyocytes were incubated (1.5 hour at 37° C) 
in phosphate free DMEM and metabolically labeled using 
phosphorus-32 (
32P).  Further incubations were conducted 
with or without CCA. The phosphorylation of samples was 
evaluated by SDS-PAGE, autoradiography, densitometry, 
and liquid scintillation counts. The findings were 
confirmed by three other experiments.  
 
 
It was suspected that PP1 and PP2A might 
exhibit further discrete substrate specificities in terms 
of dephosphorylating multiple sites on TnI (Fig. 4) 
and TnT (Fig. 5), and MLC2 (Fig. 6). We discovered 
that it was true for TnT but not true for TnI and 
MLC2 in in  vitro 
phosphorylation/dephosphorylation experiments. 
Phosphopeptide maps generated from these 
experiments showed that (a) TnI phosphopeptides are 
uniformly dephosphorylated by PP1 (Fig. 4) and (b) 
TnT phosphopeptides in spots 4A and 4B are much Int. J. Biol. Sci. 2006, 2  5
more resistant to PP1 dephosphorylation than the 
other TnT phosphopeptides (Fig. 5). The 
phosphopeptide in spot 4B is most resistant to PP1 
followed by spot 4A. The most integral finding is that, 
although the phosphopeptide in spot 5 had the 
highest  32P incorporation, it was the fastest to be 
dephosphorylated by PP1. On the other hand, spot 
4B, which was one of the least phosphorylated, 
became the most resistant to PP1 dephosphorylation. 
In vitro dephosphorylation experiments with PP2A 
did not show any preferential dephosphorylation of 
TnI and TnT (result not shown).  Phosphopeptide 
maps generated from in  situ phosphorylation 
experiment with and without CCA revealed that 
phosphopeptides in spots 2 and 4 (Fig. 7) of TnI are 
much more resistant to PP1 and PP2A than much 
larger phosphopeptides in spot 5.  
Fig. 4. Autoradiogram of 2-D peptide maps showing 
dephosphorylation of phosphopetides generated from TnI 
excised from PKC phosphorylated rat cardiac myofibrils 
and dephosphorylated by PP1, in vitro. γ-
32P labeled TnI 
was excised from the gel, extracted, and exhaustively 
trypsin digested at 37°C for 17 h. The digested 
phosphopeptide supernatant was separated and spotted on 
TLC sheets. Electrophoresis was carried out in the first 
dimension and chromatography in the second dimension. 
The phosphopeptide spots were visualized by 
autoradiography. The findings were confirmed by three 
other experiments.  
 
Fig. 5. Autoradiogram of tryptic phosphopeptide maps 
showing in vitro dephosphoryltion patterns of cardiac TnT 
maximally phosphorylated by PKC. γ-
32P labeled TnT was 
excised from the gel, extracted, and exhaustively trypsin 
digested at 37°C for 17 h. The digested phosphopeptide 
supernatant was spotted on TLC sheets. Electrophoresis 
was carried out in the first dimension and chromatography 
in the second dimension. The phosphopeptide spots were 
visualized by autoradiography. The findings were 
confirmed by three other experiments.  
 
Fig. 6. Autoradiogram of tryptic phosphopeptide maps of 
rat cardiac MLC2 in situ dephosphorylated by protein 
phosphatase in the presence and absence of CCA. γ-
32P 
labeled MLC2 was excised from the gel, extracted, and 
exhaustively trypsin digested at 37°C for 17 h. The 
digested phosphopeptide supernatant was spotted on TLC 
sheets. Electrophoresis was carried out in the first 
dimension and chromatography in the second dimension. 
The phosphopeptide spots were visualized by 
autoradiography. The findings were confirmed by three 
other experiments.  
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Fig. 7. Autoradiogram of tryptic phosphopeptide maps 2-D 
phosphopeptide map of in  situ protein phosphatase 
dephosphoylation of PKC phosphorylated TnI with and 
without CCA.  γ-
32P labeled TnI was excised from the gel, 
extracted, and exhaustively trypsin digested at 37°C for 17 
h. The digested phosphopeptide supernatant was spotted on 
TLC sheets. Electrophoresis was carried out in the first 
dimension and chromatography in the second dimension. 
The phosphopeptide spots were visualized by 
autoradiography. The findings were confirmed by three 
other experiments.  
 
 
We examined the physiological relevance of 
dephosphorylation of myofibrillar proteins in intact 
myofibrils. PP1, acting in concert with PKC and PKA 
phosphorylation, conferred substrate specificities in 
dephosphorylating contractile proteins in the thick 
and thin filaments of the cardiac myofibrils (Figs. 8, 
and 9; Table 1). The data obtained delineated that 
while PKC and PKA phosphorylation decreased Ca2+-
stimulated Mg2+ATPase activities of the rat cardiac 
myofibrils by 25%, PP1 dephosphorylation restored it 
by 24%. Also, PKA phosphorylation of the myofibrils 
decreased the Ca2+-stimulated Mg2+ATPase activities 
of the rat cardiac myofibrils by 18% while PP1 
dephosphorylation restored it by 14%. PKC and PKA 
phosphorylation decreased myofibrillar Mg2+ATPase 
activity to 75% and 81% and decreased Ca2+ 
sensitivity to 3.6 µM and 5.0 µM respectively.   
However, dephosphorylation restored myofibrillar 
Mg2+ATPase activity to 99% for PKC and 95% for 
PKA and restored Ca2+ sensitivity to (3.3 µM and 3.0 
µM, respectively) values nearly equal to or better than 
that of the control (Figs. 8, and 9; Table 1). This 
present study demonstrates for the first time, distinct 
substrate specificity of PP1 in dephosphorylating rat 
intact myofibrillar proteins.   
Fig. 8. Effects of in vitro phosphorylation (PKC) and 
dephosphorylation (PP1) of rat cardiac myofibrils on Ca
2+-
stimulated Mg
2+ATPase activity and Ca
2+sensitivity.  Ca
2+-
stimulated Mg
2+ATPase activity assay was carried out at 
30°C for 10 min in standard reaction mixtures. Kinetic data 
for Ca
2+ stimulation of Mg
2+ATPase (as a function of Ca
2+) 
was calculated. The data shown are the means ± S.E. of 
three experiments, and the curves drawn are the polynomial 
“best fits” of the data. The maximal activity obtained for 
the unphosphorylated (Control) myofibrils was taken as 
100%.  
 
Fig. 9. Effects of in vitro phosphorylation (PKA) and 
dephosphorylation (PP1) of rat cardiac myofibrils on Ca
2+-
stimulated Mg
2+ATPase activity and Ca
2+sensitivity.  Ca
2+-
stimulated Mg
2+ATPase activity assay was carried out at 
30°C for 10 min in standard reaction mixtures. Kinetic data 
for Ca
2+ stimulation of Mg
2+ATPase (as a function of Ca
2+) 
was calculated. The data shown are the means ± S.E. of 
three experiments, and the curves drawn are the polynomial 
“best fits” of the data. The maximal activity obtained for 
the unphosphorylated (Control) myofibrils was taken as 
100%.  
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Table 1. Summary of the kinetic data for Maximal Ca
2+-
stimulated Mg
2+ATPase activity and calcium sensitivity of 
phosphorylated and dephosphorylated rat cardiac 
myofibrils. The values were calculated from the data 
presented in Figs. 8 and 9, and are displayed as the means 
± S.E. of three experiments.  The maximal enzymatic 
activity is expressed as percentages of the values obtained 
from PKC or PKA phosphorylated and PP1 
dephosphorylated rat cardiac myofibrils compared to the 
unphosphorylated control, which is taken as 100%.  
 
 
4.  Discussion  
In this report, we provided unique evidence that 
PP1, a serine/threonine protein phosphatase, 
effectively dephosphorylated TnT and TnI in the thin 
filament and C-protein (as we suspected) and in 
MLC2 in the thick filament, as reported by others [6-
8]. We also reported that the in situ phosphorylation 
of rat cardiomyocytes with and without PP1 and 
PP2A inhibitor, CCA, increased the phosphorylation 
stiochiometry of TnT from 0.3 to 0.5 (67%), TnI from 
2.6 to 3.6 (38%), and MLC2 0.4 to 1.7 (325%). It was 
therefore concluded that though MLC2 is the 
preferred target substrate for PP1 in the thick filament 
[6-8], the Tn complex (TnI and TnT) is also a PP1 
substrate. It was observed that although the in situ 
phosphorylation of TnT, with and without CCA, 
appeared to be the minimal (Fig. 3) compared with 
TnI, its phosphorylation stochiometry increased 
approximately two times more than that of TnI (67% 
for TnT and 38% for TnI). The poor phosphorylation 
of TnT could be due to the fact that TnT is the 
preferred substrate of PKC-ζ,  in  situ,  which 
phosphorylated TnT very poorly in  vitro, as we 
have reported elsewhere [19, 25, 29]. On the other 
hand, TnI is a favored substrate for PKA and other 
PKC isozymes (PKC-α, -δ, and –ε) found to be 
expressed in the heart [21-25] and these isozymes 
phosphorylate TnI very well. In 1995, we reported 
that PKC isozymes (PKC-α, -δ, –ε, and –ζ) and PKA 
have specificities in phosphorylating specific sites 
within TnI [19]. It was clearly shown that the 
phosphopeptide in spot 1 contained Ser-78, spot 2 
contained Ser-43/Ser-45, spot 3 contained Thr-144, 
and spot 5 contained Ser-23/Ser-24.   
The phosphopeptide maps generated from the 
in  situ  phosphorylation of cardiomyocytes with 
and without CCA revealed that the TnI 
phosphopeptides in spots 2 and 3 are most resistant 
to PP1 dephosphorylation (Fig. 7), whereas those in 
spot 5 (Ser-23/Ser-24 (PKA and PKC-δ sites)) was 
most vulnerable to PP1 dephosphorylation since CCA 
failed in effectively protecting this site from PP1. 
Since phosphorylation sites in spots 2 and 3 are 
preferred phosphorylation sites for PKC-α, -δ and –ε, 
and PKC-δ acts as a hybrid of PKC and PKA [25] 
(which preferably share the phosphorylation of the 
phosphopeptide in spot 5), it appears that PP1 and 
PP2A dephosphorylation of these sites act in concert 
with catalyzed phosphorylation by PKC-δ and PKA.   
We reported previously that TnT 
phosphopeptide maps from in  vitro 
phosphorylation contained Thr-190 in spot 1, Ser-194 
in spot 6, Thr-199 in spot 4A, and Thr-280 in spots 3 
and 5 [19, 25, 29]. In this study, the TnT 
phosphopeptide map from 
phosphorylation/dephosphorylation revealed that 
the Thr-199 in spot 4A and the phosphopeptide in 
spot 4B were the least affected by PP1 
dephosphorylation. These phosphorylation sites are 
located in the C-terminal half of the TnT where 
binding to tropomyosin (Tm) and troponin C (TnC) 
[27, 30] occur, and most likely where TnT may 
interact with actin. These results suggest that it is 
essential to look at the physiological implications of 
PP1 dephosphorylation of the cardiac myofibrils.   
We hypothesized that PP1 will antagonistically 
affect PKC and PKA induced changes in 
Ca2+stimulated Mg2+ATPase and calcium sensitivity 
of the myofibrils. Our hypothesis was proven correct. 
Our data (Figs. 8, and 9; Table 1) reveal that while 
PKC and PKA phosphorylation decreased the Ca2+-
stimulated Mg2+ATPase activities of the rat cardiac 
myofibrils, PP1 dephosphorylation restored it close to 
that of the control values. Ca2+ sensitivity was also 
restored to values close to that of the control, 
suggesting that PP1 acts as a reset regulator of cardiac 
muscle phosphorylation.  This data agrees to that 
previously reported by others indicating that 
PP1/PP2A stimulate Ca2+ release [4, 5].  
As we and others have earlier reported, different 
PKC isozymes (PKC-α, -δ, - ε and - ζ) and PKA 
conferred changes in Ca2+-stimulated Mg2+ATPase 
activities and Ca2+ sensitivities of the rat cardiac 
myofibrils (Figs. 8, and 9; Table 1) due to their ability 
to incorporate γ-32P into specific site on TnT and TnI 
[29, 31]. PP1, on the other hand, dephosphorylated 
the same phosphopeptides phosphorylated by PKC 
and PKA. It is, therefore, expected that PP1 will 
impose an opposite effect on myofibrillar Ca2+-
stimulated Mg2+ATPase activities and Ca2+ 
sensitivities. It was observed that in most cases, there 
are differences in the extent of restoration of Ca2+-
stimulated Mg2+ATPase activities and Ca2+ 
sensitivities due to dephosphorylation. This 
discrepancy may be due to the dephosphorylation 
resistance observed on phosphopeptide spots 2 and 3 
on TnI and 4A and 4B on TnT.  
In conclusion, this investigation has proven that 
protein phosphatase has substrate specificities in Int. J. Biol. Sci. 2006, 2  8
dephosphorylating myofibrillar proteins and the 
dephosphorylation sites within them.  It has also 
shown that dephosphorylation affects Ca2+-
stimulated Mg2+ATPase activities and Ca2+ ion 
sensitivities not exactly equivalent to the extent 
incurred on them by PKC and PKA phosphorylation.   
Abbreviations  
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